0000-0002-2891-5697 About
Dr. Farha Arshi obtained her Ph.D. in Chemistry from the University of Lucknow, India, where her research focused on the synthesis, characterization, and biological evaluation of ruthenium complexes with different amines. Her work centered on developing metal-based compounds with potential anticancer and antimycobacterial applications, integrating synthetic chemistry with computational approaches to understand structure–activity relationships.
Her expertise spans coordination chemistry, medicinal chemistry, computational chemistry, molecular docking, Density Functional Theory (DFT), ADME prediction, and computer-aided drug design (CADD). She has hands-on experience in synthesizing and characterizing coordination compounds using FT-IR, UV–Visible, ¹H/¹³C NMR spectroscopy, elemental analysis, and single-crystal X-ray diffraction.
Dr. Arshi has published several peer-reviewed research articles, authored a book chapter, and presented her work at national and international scientific conferences. She has also completed specialized training in Computer-Aided Drug Design (CADD) at CSIR–Central Drug Research Institute (CDRI), Lucknow.
Her current research interests are expanding toward artificial intelligence (AI)-assisted molecular discovery, cheminformatics, RDKit, Python-based scientific computing, machine learning for molecular and materials discovery, and AI-integrated computational materials design. She is particularly interested in combining AI, quantum chemical modeling, molecular simulation, and data-driven approaches to accelerate the discovery and optimization of bioactive molecules and advanced functional materials.
Employment
-
University of Lucknow Ph.D.2020 - 2026
Education
-
University of Lucknow Ph.D.2020 - 2026
-
University of Lucknow M.Sc.2016 - 2018
-
University of Lucknow B.Sc.2013 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Exploring Schiff base and its palladium complexes: Synthesis, characterization, antimycobacterial activity, DFT, molecular docking and ADME studies Save
- Ampicillin-Derived Ruthenium Schiff Base Complexes as Emerging Anticancer and Antimicrobial Candidates: Synthesis, Characterization, DFT, ADME and Molecular Docking Save
- Comprehensive Exploration of Ampicillin-Schiff Base Complexes: Synthesis, DFT Insights, Molecular Docking, and Biotherapeutic Applications Save
- Design, Synthesis, and Biological Insights of Half Sandwich Ruthenium–Arene Schiff Base Complexes: Molecular Docking and DFT Save
- New Ru(III) 2,6-Bis(2-Benzimidazolyl)Pyridine Complexes Bearing P-Sub-Benzyl Thiosemicarbazones Schiff Base: Synthesis, Characterization, DNA Binding and Anti-cancer Activity Save
- Synthesis, Characterization and Biological Evaluation of Ruthenium Complexes with Different Amines Save
- Synthesis, DFT Calculation, DNA Binding, and Biological Evaluation of Some Mononuclear Ru(III) Сomplexes with 2,6-Bis(2-benzimidazolyl)pyridine Bearing Different p-Substituted Heterochalcones Save
- Synthesis, Characterization, Molecular Docking and Biological Evaluation of Ruthenium Complexes Save
- Design, Synthesis, Theoretical, Spectroscopic and Molecular Docking Studies of Ruthenium and Zinc Complexes and their Antimycobacterial Study Save